News
Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report)‘s stock had its “neutral” rating reaffirmed by research analysts at ...
Designed to provide broad exposure to the Health Care ETFs category of the market, the First Trust Health Care AlphaDEX ETF (FXH) is a smart beta exchange traded fund launched on 05/08/2007. What Are ...
Stock analysts at StockNews.com initiated coverage on shares of Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) in a ...
Rigel Pharmaceuticals is now reporting net income and has three marketed drugs, all of which can continue to grow. Read more ...
Designed to provide broad exposure to the Small Cap Blend segment of the US equity market, the Schwab U.S. Small-Cap ETF (SCHA) is a passively managed exchange traded fund launched on 11/03/2009. The ...
11h
Zacks Investment Research on MSNShould John Hancock Multifactor Small Cap ETF (JHSC) Be on Your Investing Radar?The John Hancock Multifactor Small Cap ETF (JHSC) was launched on 11/08/2017, and is a passively managed exchange traded fund designed to offer broad exposure to the Small Cap Blend segment of the US ...
Vanguard's index fund lineup continues to grow and cut costs. Here's a look at the most popular picks.
3d
Zacks Investment Research on MSNIs John Hancock Multifactor Small Cap ETF (JHSC) a Strong ETF Right Now?A smart beta exchange traded fund, the John Hancock Multifactor Small Cap ETF (JHSC) debuted on 11/08/2017, and offers broad exposure to the Style Box - Small Cap Blend category of the market. What ...
UBS reaffirmed its Buy rating on Johnson & Johnson (NYSE:JNJ) and maintained a $180 price target, but highlighted short-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results